|
Zebrafish models of human leukemia and sarcoma
|
Z01 BC 010549
|
$687,101
|
$206,130
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$37,420
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
$333,235
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Web-based Family History Screening for Hereditary Breast Cancer Risk
|
1R21CA127837-01
|
$185,400
|
$185,400
|
ACHESON, LOUISE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-03
|
$244,382
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Vascular Leukocytes influence the tumor microenvironment
|
1R01CA124515-01A1
|
$303,810
|
$303,810
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
Vascular Leukocytes Induce Treg in Tumors
|
5R01CA116779-02
|
$271,456
|
$135,728
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$40,866
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
$394,704
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-29
|
$2,094,891
|
$691,314
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S1
|
$75,930
|
$3,797
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S2
|
$172,091
|
$8,605
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S3
|
$175,726
|
$8,786
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-23
|
$1,493,701
|
$74,685
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-08
|
$2,249,522
|
$2,249,522
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
$2,371
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
$4,560
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
$237,165
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$589
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
$2,758
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S2
|
$2,553,879
|
$102,155
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S3
|
$59,791
|
$2,392
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S2
|
$3,773,055
|
$75,461
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S3
|
$78,561
|
$1,571
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Tumor-priming Microparticles for Pancreatic Cancer
|
5R44CA103133-04
|
$565,979
|
$282,990
|
LU, ZE
|
OPTIMUM THERAPEUTICS, LLC
|
|
Tumor-Associated Antigens in Early Stage Serous Carcinoma
|
5R01CA122581-02
|
$301,831
|
$301,831
|
RODEN, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor plasmacytoid dendritic cells and tumor immunity
|
5R01CA092562-05
|
$251,461
|
$251,461
|
ZOU, WEIPING
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Tumor metastasis: Biobehavioral mechanisms
|
5R01CA110793-04
|
$329,855
|
$329,855
|
SOOD, ANIL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor maintenance and development in mouse models
|
5U01CA105492-04
|
$458,655
|
$151,356
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tumor Host Range Mutants of Polyoma and Their Targets
|
5R01CA092520-07
|
$597,353
|
$597,353
|
BENJAMIN, THOMAS
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S2
|
$4,309,306
|
$43,093
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S3
|
$57,159
|
$572
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-03
|
$1,235,688
|
$420,134
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Transforming growth factor beta signaling pathways
|
2R01CA055536-16
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Total Synthesis of Anticancer Agents Superstolides A & B
|
1R01CA109208-01A2
|
$210,000
|
$52,500
|
JIN, ZHENDONG
|
UNIVERSITY OF IOWA
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-11
|
$203,525
|
$81,410
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Topoisomerase I Inhibitors in Leukemia and Solid Tumors
|
5R01CA073709-09
|
$221,813
|
$55,453
|
KAUFMANN, SCOTT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Tissue Microarray Design and Development for Novel Gene and Gene Product Screenin
|
Z01 SC 010364
|
$515,375
|
$25,769
|
Kleiner, David
|
CCR (NCI)
|
|
Therapeutic targeting of HSP90-dependent singnaling
|
5R01CA104378-04
|
$258,036
|
$258,036
|
KARNITZ, LARRY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-03S1
|
$135,561
|
$135,561
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-03S2
|
$50,652
|
$50,652
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-03
|
$309,920
|
$309,920
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
|
Z01 SC 000165
|
$357,224
|
$89,306
|
Birrer, Michael
|
CCR (NCI)
|
|
The roles of XPF/ERCC1 complex in DNA repair
|
5R01CA095291-05
|
$231,724
|
$115,862
|
BESSHO, TADAYOSHI
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
The role of complement in ovarian cancer
|
5R01CA112162-03
|
$296,817
|
$296,817
|
LAMBRIS, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of CD95 as a Tumor Promoter
|
5R01CA112240-03
|
$287,453
|
$94,859
|
PETER, MARCUS
|
UNIVERSITY OF CHICAGO
|
|
The role of BRCA1 in nonhomologous repair of chromosomal double-strand breaks
|
5R01CA118158-02
|
$238,105
|
$119,053
|
Xia, Fen
|
VANDERBILT UNIVERSITY
|
|
The Regulation of UPA and UPAR in Human Carcinoma Cells
|
7R01CA093926-06
|
$232,488
|
$116,244
|
HUANG, SHUANG
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
$4,655
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
$1,698
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Ovarian Cancer for this search: $96,933,271
|